“Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s102. doi:10.25251/skin.6.supp.102.